Vanguard Group Inc. Purchases 220,386 Shares of Celcuity, Inc. $CELC

Vanguard Group Inc. lifted its holdings in Celcuity, Inc. (NASDAQ:CELC) by 10.7% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,279,433 shares of the company’s stock after buying an additional 220,386 shares during the period. Vanguard Group Inc.’s holdings in Celcuity were worth $227,351,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Ogorek Anthony Joseph NY ADV purchased a new stake in shares of Celcuity during the third quarter valued at approximately $27,000. US Bancorp DE boosted its position in Celcuity by 25.4% in the third quarter. US Bancorp DE now owns 706 shares of the company’s stock worth $35,000 after purchasing an additional 143 shares during the last quarter. NBC Securities Inc. purchased a new position in Celcuity in the fourth quarter worth $99,000. Versant Capital Management Inc grew its stake in Celcuity by 611.2% in the 3rd quarter. Versant Capital Management Inc now owns 1,593 shares of the company’s stock valued at $79,000 after purchasing an additional 1,369 shares during the period. Finally, Everhart Financial Group Inc. bought a new position in Celcuity in the 4th quarter valued at $209,000. 63.33% of the stock is owned by institutional investors.

Insider Activity

In other news, Director David Dalvey sold 25,000 shares of Celcuity stock in a transaction dated Monday, May 4th. The shares were sold at an average price of $140.68, for a total value of $3,517,000.00. Following the completion of the transaction, the director owned 65,000 shares in the company, valued at $9,144,200. This trade represents a 27.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Richard E. Buller sold 9,000 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were sold at an average price of $140.46, for a total transaction of $1,264,140.00. Following the completion of the sale, the director directly owned 6,760 shares in the company, valued at approximately $949,509.60. This trade represents a 57.11% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 37,000 shares of company stock worth $5,111,950. Insiders own 13.33% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on CELC shares. Wolfe Research reiterated an “outperform” rating and set a $110.00 target price on shares of Celcuity in a research note on Thursday, March 12th. Stifel Nicolaus set a $150.00 price target on shares of Celcuity in a research report on Monday, May 4th. Citizens Jmp lifted their price objective on shares of Celcuity from $150.00 to $160.00 and gave the stock a “market outperform” rating in a research report on Monday, May 4th. Craig Hallum reiterated a “buy” rating and issued a $189.00 target price on shares of Celcuity in a research note on Monday, May 4th. Finally, Guggenheim increased their target price on shares of Celcuity from $135.00 to $165.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Ten analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $134.50.

Celcuity Stock Performance

Shares of CELC opened at $131.06 on Friday. Celcuity, Inc. has a 1 year low of $9.51 and a 1 year high of $151.02. The company has a debt-to-equity ratio of 3.20, a current ratio of 10.55 and a quick ratio of 10.55. The stock’s fifty day moving average price is $116.46 and its two-hundred day moving average price is $104.45. The firm has a market cap of $6.34 billion, a PE ratio of -34.58 and a beta of 0.09.

Celcuity (NASDAQ:CELC) last posted its quarterly earnings results on Wednesday, March 25th. The company reported ($0.97) earnings per share for the quarter, topping the consensus estimate of ($1.06) by $0.09. On average, equities research analysts forecast that Celcuity, Inc. will post -3.87 EPS for the current year.

About Celcuity

Celcuity, Inc is a clinical-stage biotechnology company specializing in precision oncology diagnostics. The company develops and commercializes predictive biomarker assays designed to identify which patients are most likely to benefit from targeted cancer therapies. By integrating functional profiling of tumor cells with molecular analyses, Celcuity seeks to optimize treatment selection and improve outcomes for patients with solid tumors.

Celcuity’s proprietary platform evaluates tumor cell sensitivity to various therapeutic agents using ex vivo assays that measure DNA damage response and other critical pathways.